ANGIODYNAMICS INC 8-K

What Happened
AngioDynamics, Inc. (ANGO) filed an 8-K on January 6, 2026 to announce its financial results for the fiscal second quarter ended November 30, 2025. The company furnished a press release reporting those results (Exhibit 99.1) and presentation slides discussing the quarter (Exhibit 99.2). The 8-K itself does not include the numeric results — readers should review the attached press release and slides for the full financial details.

Key Details

• Filing date: January 6, 2026 (Form 8-K).
• Period reported: Fiscal second quarter ended November 30, 2025.
• Exhibits furnished: Exhibit 99.1 — press release dated January 6, 2026; Exhibit 99.2 — presentation slides dated January 6, 2026.
• Reported under Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure).

Why It Matters
Earnings releases and accompanying slides are primary sources for current revenue, profit, and other quarterly results; they can affect investor perception and share price. Because the 8-K furnishes the press release and presentation but does not restate figures within the filing, investors should open Exhibits 99.1 and 99.2 to see the reported revenue, earnings, segment performance, and any management commentary or guidance disclosed for Q2 FY2026.